You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Changes in clinical trial length
|
|---|---|
| Published in |
Nature Reviews Drug Discovery, April 2015
|
| DOI | 10.1038/nrd4611 |
| Pubmed ID | |
| Authors |
Lisette Pregelj, Martie-Louise Verreynne, Damian Hine |
X Demographics
The data shown below were collected from the profiles of 50 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 7 | 14% |
| United States | 5 | 10% |
| Switzerland | 2 | 4% |
| France | 2 | 4% |
| Russia | 1 | 2% |
| China | 1 | 2% |
| Netherlands | 1 | 2% |
| Thailand | 1 | 2% |
| South Africa | 1 | 2% |
| Other | 4 | 8% |
| Unknown | 25 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 41 | 82% |
| Scientists | 8 | 16% |
| Practitioners (doctors, other healthcare professionals) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 4% |
| United Kingdom | 1 | 2% |
| Austria | 1 | 2% |
| Switzerland | 1 | 2% |
| Unknown | 45 | 90% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 22% |
| Student > Bachelor | 8 | 16% |
| Other | 7 | 14% |
| Student > Ph. D. Student | 6 | 12% |
| Professor | 3 | 6% |
| Other | 9 | 18% |
| Unknown | 6 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 10 | 20% |
| Chemistry | 7 | 14% |
| Medicine and Dentistry | 7 | 14% |
| Agricultural and Biological Sciences | 5 | 10% |
| Business, Management and Accounting | 3 | 6% |
| Other | 8 | 16% |
| Unknown | 10 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 50. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2022.
All research outputs
#842,075
of 25,387,480 outputs
Outputs from Nature Reviews Drug Discovery
#392
of 3,648 outputs
Outputs of similar age
#10,061
of 274,060 outputs
Outputs of similar age from Nature Reviews Drug Discovery
#9
of 68 outputs
Altmetric has tracked 25,387,480 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,648 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,060 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.